News | April 05, 2007

MedicalCV’s Ablation Device Used in Closed-Chest Robotic Cardiac Procedure

April 6, 2007 — MedicalCV Inc., Minneapolis, MN, has announced that Allen R. Raczkowski, M.D., director of Robotic Cardiac Surgery at Banner Baywood Health Systems in Mesa, AZ, performed a closed-chest, robotic, lone cardiac ablation procedure on an arrested heart on March 30 using the ATRILAZE Surgical Ablation System.

"With a clinical history of unsuccessful medical treatment and interventional ablations, this patient was an ideal candidate for a minimally invasive operation. The versatility of the ATRILAZE wand allowed me to create the critical lesion sets with robotic assistance, providing the greatest chance of helping this patient," said Dr. Raczkowski, a leading pioneer in minimally invasive cardiac surgery. "I look forward to utilizing this and additional surgical ablation products from MedicalCV in the future."

The ATRILAZE Surgical Ablation System is a laser-based technology platform that provides cardiac tissue ablation in both open and endoscopic surgeries. The system is FDA cleared for ablation or coagulation of soft tissue, including cardiac tissue, but in the U.S. its use in treating cardiac arrhythmias is specifically excluded. To date, the product has been used in numerous institutions around the country including Baylor University Medical Center, Northwestern University Medical Center, Central DuPage Hospital, Baptist Medical Center in San Antonio, Texas, and Scottsdale Healthcare - Osborn in Arizona.

For more information visit www.medcvinc.com.


Related Content

News

Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...

Home October 13, 2025
Home
News

Sept. 2, 2025 — Johnson & Johnson MedTech has announced acute safety and effectiveness results from the Varipure ...

Home September 05, 2025
Home
News

Sept. 3, 2025 — Kardium Inc. recently announced it has received pre-market approval (PMA) for the Globe Pulsed Field ...

Home September 03, 2025
Home
News

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

Home July 14, 2025
Home
News

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...

Home July 09, 2025
Home
News

June 4, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...

Home June 04, 2025
Home
News

April 24, 2025 – The Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) have released a scientific ...

Home April 24, 2025
Home
News

April 9, 2025 — Merit Medical Systems has announced the U.S. commercial release of its Ventrax Delivery System. Ventrax ...

Home April 16, 2025
Home
News

March 27, 2025 — Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients ...

Home March 27, 2025
Home
News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
Subscribe Now